(Q37292055)
Statements
1 reference
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2. (English)
1 reference
Qin Ryan
1 reference
Amna Ibrahim
1 reference
Martin H Cohen
1 reference
John Johnson
1 reference
Chia-wen Ko
1 reference
Rajeshwari Sridhara
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
10 October 2008
1 reference
1 reference
13
1 reference
10
1 reference
1114-1119
1 reference
Identifiers
1 reference
1 reference